Introduction
============

Breast cancer is the most common malignancy among women in the United States \[[@r1]\]. Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous pollutants formed from incomplete combustion ([@r10]). PAHs are genotoxic prooxidants, confirmed human lung carcinogens, and potent mammary carcinogens in laboratory animals \[[@r28]\]. However, the association between PAHs and breast cancer in women is unclear ([@r20]). Previous population studies have reported associations between PAH-related exposures and breast cancer. For example, PAHs bind to DNA, including in breast tissue, and the resulting DNA adducts have been associated with breast cancer in epidemiological studies, although the research is scant ([@r21]; [@r46]). PAH--DNA adducts reflect short-term exposures ([@r21]), whereas breast cancer is thought to develop over many years. Thus, it is of interest to evaluate longer-term PAH exposures in relation to breast cancer risk.

Vehicular traffic is a major ambient source of PAH exposure, especially near urban areas ([@r17]). To our knowledge, all previous studies on traffic or air pollution exposure and breast cancer have reported some positive associations between breast cancer and at least one air pollution exposure surrogate ([@r8]; [@r14]; [@r33]; [@r39]; [@r42]). In some cases, the effect estimates were close to the null \[for example, 1.16 (0.89, 1.51); [@r42]\]. The exposure assessment methods in these previous reports varied. Some investigations relied on simple traffic density data or sparse monitors, evaluated relatively brief periods of exposure, or focused on nitrogen oxides rather than carcinogenic particulate pollution. Further progress requires sophisticated modeling to reconstruct long-term cumulative exposures to ambient PAHs.

Breast cancer risk factor profiles differ by menopausal status and tumor subtype ([@r1]; [@r11]), and fruits and vegetables may modify the carcinogenic effects of PAHs via antioxidant and other chemopreventive properties ([@r25]; [@r29]). However, whether the association between ambient PAHs and breast cancer varies by fruit/vegetable intake, tumor characteristics, or menopausal status is not well understood.

Our population-based study aimed to estimate the association between breast cancer incidence and vehicular traffic, overall and within subgroups of women classified according to fruit/vegetable intake, menopausal status, and tumor subtype. For the study reported here, we used long-term, individualized residential traffic benzo\[*a*\]pyrene (B\[*a*\]P) exposure estimates (as a proxy for exposure to particulate traffic PAHs), which were reconstructed using a historical, geographic exposure model that was consistent with a varied set of environmental measurements ([@r2]). It is important to help clarify the association between traffic PAHs and breast cancer given the high incidence of breast cancer and broad exposure to traffic pollution worldwide.

Materials and Methods
=====================

We used resources from the case--control component of the Long Island Breast Cancer Study Project (LIBCSP), a population-based investigation conducted among women residing in Nassau and Suffolk counties in Long Island, New York ([@r19]). All participating institutions provided institutional review board approval for this study, and all participants gave their written informed consent prior to study enrollment.

*Study population*. Eligible case participants were diagnosed with a first primary invasive or *in situ* breast cancer between August 1996 and July 1997 and were identified via rapid case ascertainment through contact with local pathology departments ([@r19]). Eligible control participants were women with no history of breast cancer and were identified using random digit dialing ([@r54]) for women \< 65 years old and Health Care Finance Administration records for women ≥ 65 years old. Controls were frequency matched based on the expected 5-year age distribution among the case participants. Case--control sample sizes taking into account LIBCSP subject selection procedures, participation rates, and vehicular traffic exposure data availability are presented in the Supplemental Material, Table S1.

The respondents included 1,508 case participants and 1,556 control participants (82.1% and 62.7% of eligible participants, respectively), who ranged between 20 and 98 years of age and were mostly postmenopausal (67.4%) and white (92.8%); the racial distribution reflects that of the study counties at the time of data collection ([@r19]). More than 50% of the study participants reported a household income ≥ \$50,000 in the year prior to the study interview ([@r19]). Among women with traffic exposure information in the year 1995, 203 presented with *in situ* breast cancer and 1,071 presented with invasive breast cancer.

In previous LIBCSP reports, we found that breast cancer incidence was associated with early age at menarche, few or no births, and little or no breastfeeding ([@r19]; [@r49]); increased body size ([@r15]); little or no physical activity ([@r34]); low fruit/vegetable intake ([@r22]); low flavonoid intake ([@r16]); increased blood levels of PAH--DNA adducts ([@r21]); long-term residential environmental tobacco smoke exposure ([@r18]); and increased grilled/smoked food intake ([@r51]).

*Study questionnaire*. Trained interviewers administered an at-home, 2-hr structured questionnaire within a few months of diagnosis (case participants) or study recruitment (control participants). Detailed questionnaire information included residential history, household income, educational attainment, race, religion, reproductive and medical histories, smoking, exogenous hormone use, and body size ([@r19]). A validated Block food frequency questionnaire ([@r6], [@r7]) was self-completed by 98% of case and control participants and assessed typical dietary intake during the year prior to the interview, including intake of fruits, fruit juices, and vegetables ([@r22]).

*Tumor Subtypes*. Medical records were abstracted for 1,402 case participants to ascertain tumor estrogen and progesterone receptor (ER/PR) status subtypes ([@r19]; [@r55]; [@r56]). Mutations in exons 5--8 of the tumor p53 gene (*TP53*) were determined using archived, paraffin-embedded tissue (*n* = 859) ([@r43]). Briefly, the extracted tumor DNA was amplified using polymerase chain reaction (PCR), screened via the Surveyor Mutation Detection Kit (Transgenomic, Omaha, NE, USA), and possible mutations were confirmed with an ABI 3100 capillary sequencer (Applied Biosystems Inc, Foster City, CA, USA).

*Traffic B\[*a*\]P exposure assessment*. Interviewers collected information regarding participants' lifetime residential histories in Nassau and Suffolk counties only. Addresses at which a woman resided for at least 1 year were recorded and geocoded using BLR software (now part of Geographic Data Technology Inc., Lebanon, NH). Digital street maps were based on Census "Tiger" maps (<http://www.census.gov/geo/maps-data/data/tiger.html>), which provide residence numbers at the start and end of a straight line street segment. The locations of intervening residence numbers were obtained by linear interpolation. The percentage of addresses that geocoded successfully ranged between 60% in the 1960s and 85% in 1995 ([@r3]), and 87% of participants provided at least one address that geocoded to the street level.

The traffic B\[*a*\]P exposure model ([@r3], [@r2], [@r5]) used a road network comprising approximately 500,000 street segments in the New York metropolitan area, which includes Nassau and Suffolk counties. Emissions for each street segment were calculated as the product of hourly roadway-specific traffic counts and average U.S. tailpipe emissions for the years 1960, 1970, 1980, and 1990. Estimates for other years between 1960 and 1995 were derived via interpolation or extrapolation. Vehicular traffic B\[*a*\]P estimates included adjustment for acceleration/deceleration at intersections ([@r2]). Emissions within 80 km of the study area were directly calculated, and the exposure model also included a background term (proportional to exposures from the 22 counties just outside of the 2-county study area) to account for more distant roads ([@r2]). Tailpipe emission parameters were derived from road tunnel measurements throughout the United States and were checked using measurements on vehicles run on dynamometer test beds ([@r4]). As previously reported by [@r2], roadway traffic counts were obtained from over 13,000 annual average daily traffic measurements recorded in state and county records. All roads for which traffic counts were collected on Long Island by New York State, New York City, and Nassau and Suffolk counties were included in the direct emission model. Traffic counts for Nassau and Suffolk counties were taken from paper maps and entered into a geographic information system (see Supplemental Figure S1). For other counties, those roads for which counts were collected by New York State were included. Additional road counts were assumed to be proportional to the counts on major roads. Then, it was possible to scale "outer county" emissions to estimate total emissions from these counties, obtaining the scale factor as part of the fit to soil PAH data in the yards of study participants.

Roadway emissions were translated into predicted residential ambient B\[*a*\]P concentrations, considered a surrogate for exposure to all traffic PAHs, using standard meteorological dispersion and deposition models ([@r2]; [@r12]; [@r53]). Up to 100 m from a road, traffic B\[*a*\]P levels were estimated using highway line-source puff models ([@r12]). Beyond 100 m, a standard Gaussian plume model with Briggs dispersion parameters ([@r53]), which incorporated data on wind speed and direction, rain washout, photo decay, and particle deposition, was used ([@r2]). Meteorological data were collected at Brookhaven National Laboratory (year 1993), which was used as the standard for all years between 1960 and 1995. Changing the year (1990) or location (MacArthur Airport) of meteorological data collection for a sensitivity analysis did not appreciably alter exposure estimates ([@r3]).

*Model validation*. The exposure model was modified to predict measured residential soil and carpet PAH levels among women living at their current address for at least 15 years, PAH--DNA adduct levels in circulating mononuclear cells collected at the time of the interview, and monitoring data for carbon monoxide, a traffic-related pollutant. Details of the model validation process are described by [@r2]. Briefly, the model predicted soil PAHs, PAH--DNA adduct levels, and carbon monoxide concentrations, but not PAH levels in carpet dust. Specifically, when model predictions were compared with soil data, no deviation from linearity was apparent, and the *R*^2^-value was 86%. The fit to quantile data for PAH--DNA adducts was similar, though not quite as strong, with an *R*^2^-value of 58%. When examining the fit of the model to hourly CO data, the *R*^2^-value was 63%, even though the *R*^2^-value for the correlation between hourly CO emissions and concentrations was only 3.3% owing to the lag between CO emissions from tailpipes and the time of reaching distant receptors. Finally, although our model predicted that carpet PAH levels would diminish across zones of urbanization, the carpet PAH levels actually peaked at the center of the "zones" ([@r2]). The latter finding is consistent with a study showing that residential ambient PAH concentrations do not correlate with house dust PAH levels ([@r17]).

The model was calibrated against soil and PAH--DNA adduct data through chi-squared minimization ([@r2]). The soil-calibrated model provided the best fit to field data and was therefore used for regressions against breast cancer incidence. Emissions during engine warm-up, which were included during model building, did not contribute to predicting soil PAH levels in validation exercises and were dropped from the exposure model ([@r2]).

*Missing exposure data*. Residential histories during 1960--1995 were incomplete for study participants who migrated to Long Island from other locations or whose recollection of prior addresses was incomplete ([@r5]). We estimated emissions during these time periods by imputing values for the dispersion or transfer of emissions from the entire road network to exposure at individual residences, referred to as the *D*-value. *D*-values tend to be roughly constant over historical time, changing only as the relative traffic pattern changes in different parts of the modeling region.

For time spent outside of the study area, we used a random variable with a lognormal distribution whose mean was the average estimated traffic B\[*a*\]P concentration on Long Island during the relevant period, based on 5-year intervals. We used multiple imputation (MI) to derive the variance of the random *D*-value, which was set equal to the variance of *D*-values for women in the study area during the same 5-year interval used to compute the mean ([@r5]; [@r45]).

When the specific location of a residence within the Long Island study area was not known, the *D*-value was imputed by interpolating between values at residences before and after the missing value ([@r5]), as suggested by [@r42]. To obtain values that differed between imputed data sets, we multiplied the interpolated *D*-value by a random number with a log normal distribution whose variance was taken from a lognormal fit to the two *D*-values used for interpolation. If the missing *D*-value was the first or last *D*-value for a study participant, extrapolation was used. For each of 30 imputed data sets, distinct values were randomly drawn from the derived lognormal distributions used to pick imputed *D*-values.

*Statistical methods*. We evaluated cumulative vehicular traffic B\[*a*\]P exposures for the year 1995 (the year prior to case ascertainment) and for the period 1960--1990. For 1995 exposures, we conducted a complete case analysis (CCA), in which all participants had complete, unimputed exposure information. For 1960--1990 exposures, we restricted analyses to women with ≤ 20% of their total cumulative exposure imputed ([@r5]). We also conducted a sensitivity analysis restricting allowed imputation percentage by exposure duration rather than percentage of cumulative exposure level, as well as conducting a CCA for associations with 1960--1990 exposure. We selected a range of exposure durations in order to maximize study power, which was higher for recent exposures, in addition to benefiting from long-term cumulative exposure information. We also removed the contribution of intersections from the exposure model and imputed missing exposures according to census place (i.e., city, town, or village) ([@r5]). Emissions at intersections contribute strongly to total traffic PAH exposure because of the increased acceleration/deceleration that takes place in these locations ([@r2]).

We calculated descriptive statistics for the exposure variables, overall and by case--control status, and evaluated Spearman and Pearson correlations ([@r44]) between selected exposure variables. Pearson correlation is more sensitive to outliers and the upper tails of a distribution than Spearman correlation. "Outlier" exposure estimates in our study reflected truly increased exposures for these individuals owing to proximity to heavily trafficked intersections ([@r2], [@r5]). Thus, Pearson coefficients may be informative when considering women with the highest exposure levels, but Spearman coefficients are likely to be more representative of the overall ranking for most participants.

Exposure levels were normalized to the average B\[*a*\]P exposure in 1995 and expressed as relative units ([@r5]) in order to avoid interpreting results as stemming from specific B\[*a*\]P exposure levels; rather, B\[*a*\]P is to be considered a proxy for all traffic PAHs.

Statistical analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC).

Prior to undertaking regression analyses, we used age-adjusted cubic smoothing splines with knots at each unique exposure value ([@r24]) to evaluate the association between traffic-related B\[*a*\]P exposure (during 1995 and 1960--1990) and breast cancer incidence. The spline figures for both short- and long-term exposures indicated that the association was not linear (data not shown) and were used to generate traffic B\[*a*\]P quantile cut points for regression models: \< 50th (referent), 50th to \< 75th, 75th to 95th, and ≥ 95th percentiles. We are precluded from showing these figures because of stipulations in the LIBCSP's consent forms and IRB approval regarding presenting results for individual women or groups comprising fewer than five participants because the figures would single out women with high traffic PAH exposure levels.

We used unconditional logistic regression ([@r27]) to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations between traffic B\[*a*\]P estimates and breast cancer incidence. When using partially imputed exposure variables, effect estimates and confidence limits were combined across 30 imputations using Rubin's rules ([@r45]).

All regression models were adjusted for the case--control frequency-matching factor, 5-year age group ([@r19]). Other potential confounders \[educational level (less than high school, high school graduate, some college, college graduate, or post-college), annual household income (\< \$15,000, \$15,000--\$19,999, \$20,000--\$24,999, \$25,000--\$34,999, \$35,000--\$49,999, \$50,000--\$69,999, \$70,000--\$89,999, or ≥ \$90,000), race (white, black, or other), religion (none, Protestant, Catholic, Jewish, or other), parity (continuous), age at first birth (continuous), body mass index (kilograms per meter squared, continuous) duration of oral contraceptive use (continuous), lifetime average alcohol intake (never drinkers, \< 15 g/day, 15--30 g/day, ≥ 30 g/day), lifetime average physical activity (in hours per week: none, low, average, and high), and duration of breastfeeding (continuous)\] were identified by a thorough literature review and analysis of directed acyclic graphs ([@r50]) and were evaluated for model inclusion using a 10% change-in-estimate criterion relative to age-adjusted models ([@r44]). No covariates altered age-adjusted effect estimates for the year 1995 or for the period 1960--1990 by 10% or more. We present the results as age-adjusted models as well as models adjusted for all potential confounders.

We explored effect modification by menopausal status (pre- vs. postmenopausal) and by fruit/vegetable intake in the year prior to the study interview (≤ 34 vs. ≥ 35 servings/week) for 1995 and 1960--1990 exposures using stratified analyses and likelihood ratio tests for multiplicative interaction ([@r44]). Menopausal status was defined using data from the study questionnaire, which was collected during the case--control interview ([@r49]). Specifically, menopausal status was defined according to information on participants' last menstrual period, history of hysterectomy or bilateral oophorectomy, smoking status, and hormone replacement therapy use ([@r49]). Fruit/vegetable intake was dichotomized based on previously reported associations with breast cancer incidence in the LIBCSP ([@r22]).

We used age-adjusted polytomous logistic regression models ([@r27]) to estimate associations between traffic B\[*a*\]P and breast cancer, with cases categorized according to tumor *TP53* mutation status and hormone receptor status subtypes and by whether tumors presented as invasive or *in situ*. Polytomous regression simultaneously generates effect estimates for several groups in relation to control participants. The ratios of the odds ratios and 95% CIs ([@r47]) for these associations were then used to formally evaluate the heterogeneity of the effect estimates across tumor types \[*TP53* mutation-positive vs. *TP53* mutation-negative, *in situ* vs. invasive, ER+PR+ vs. all other subtypes (ER--/PR+, ER+/PR--, or ER--/PR--), and ER--PR-- vs. all other subtypes (ER+/PR--, ER--/PR+, or ER+/PR+)\]. The upper exposure quantiles (75th to \< 95th and ≥ 95th percentiles) were collapsed when cell sizes comprised fewer than 10 participants.

Results
=======

The number of LIBCSP respondents for whom traffic B\[*a*\]P estimates were available (520--1,274 case participants; 566--1,334 control participants) varied according to the exposure definition and the imputed data set (some women exceeded the limit on imputation percentage in certain imputation draws), and the participants showed a wide range of exposure levels ([Table 1](#t1){ref-type="table"}). Mean estimated exposures were consistently higher among case particpants than control participants ([Table 1](#t1){ref-type="table"}). In the year 1995, mean exposures were 1.03 and 0.97 units for participants in the case and control groups, respectively. The corresponding mean levels for cumulative exposure in 1960--1990 were 227.42 and 196.71 units, where each unit corresponds to one year's worth of average exposure in 1995.

###### 

Residential vehicular traffic benzo\[a\]pyrene exposure estimates by case--control status, Long Island Breast Cancer Study Project, 1996--1997.

  Traffic PAH exposure years^*a*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Cases (*n* = 1,508)   Controls (*n* = 1,556)              
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------- ------------------------ ---------- -----------------
  1995 (CCA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1,274                 1.03 (0.62)              1,334      0.97 (0.55)
  1960--1990 (≤ 20% MI)^*b*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               520--551              227.42 (125.31)          566--597   196.71 (122.06)
  Abbreviations: CCA, complete case analysis; IQR, interquartile range; MI, multiple imputation. ^***a***^Exposure levels were normalized to the average B\[*a*\]P exposure in 1995 and expressed as relative units in order to avoid interpreting results as stemming from specific B\[*a*\]P exposure levels. Rather, B\[*a*\]P is to be considered a proxy for all traffic PAHs. Mean values for multiple years represent cumulative versus mean annual exposure. ^***b***^Combined over 30 imputations. Sample size varies across imputed data sets.                                                             

Short-term (1995) and long-term \[1960--1990 (20% MI)\] exposure estimates were correlated (Spearman correlation coefficient: *r* = 0.76, Pearson correlation coefficient: *r* = 0.41; see Supplemental Material, Table S2).

Adjusted cubic spline figures suggested an increase in breast cancer incidence among women with the top 1% of traffic B\[*a*\]P exposure levels in 1995 and in 1960--1990 (data not shown). These results are based on a small number of women. Hence, we used broader quantiles (≥ 95th percentile, 75th to \< 95th percentile, 50th to \< 75th percentile, \< 50th percentile) in regression models for 1995 and 1960--1990 in order to stabilize the results, which are presented in [Table 2](#t2){ref-type="table"}. Age-adjusted ORs from logistic regression models comparing participants with the top 5% of exposure levels to those with exposures below the median were 1.14 (95% CI: 0.80, 1.64) for 1995 exposure (complete case analysis), and 1.44 (95% CI: 0.78, 2.68) for cumulative exposure during 1960--1990 (among women with ≤ 20% of their total exposure based on imputed values) ([Table 2](#t2){ref-type="table"}). Effect estimates were similar when adjusting for the full set of potential confounders, especially for the 1960--1990 results ([Table 2](#t2){ref-type="table"}). Restricting participants' imputation percentage by exposure duration rather than by percentage of cumulative exposure level did not alter results for the association between 1960--1990 traffic PAHs and incident breast cancer (data not shown). Associations for 1960--1990 (CCA) were also similar to the results for 1960--1990 with 20% MI (data not shown). After removing the contribution of intersections from the exposure model, we observed null associations between traffic PAH exposure and breast cancer risk (even among women with the highest exposures) which is consistent with a previous LIBCSP report indicating the importance of intersection emissions to total exposure ([@r2]). However, interactions with fruit/vegetable intake were still evident (data not shown).

###### 

Associations between varying time ranges of exposure to benzo\[a\]pyrene from residential vehicular traffic and breast cancer incidence, Long Island Breast Cancer Study Project, 1996--1997.

  Traffic PAH exposure years/percentile of exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Age-adjusted models   Fully-adjusted models^*a*^                                             
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------- ---------------------------- ------------------- ---------- ---------- -------------------
  1995 (CCA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  \< 50th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   645                   659                          1.00 (referent)     606        620        1.00
  50 to \< 75th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             299                   353                          0.87 (0.72, 1.04)   281        330        0.78 (0.63, 0.98)
  75 to \< 95th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             260                   261                          1.01 (0.82, 1.23)   241        251        1.02 (0.80, 1.30)
  ≥ 95th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    70                    61                           1.14 (0.80, 1.64)   67         58         1.06 (0.70, 1.60)
  1960--1990 (≤ 20% MI)^*b*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  \< 50th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   262--287              289--320                     1.00 (referent)     244--267   274--304   1.00
  50 to \< 75th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             122--139              136--155                     0.99 (0.73, 1.36)   113--130   126--142   0.97 (0.66, 1.42)
  75 to \< 95th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             96--111               111--121                     0.95 (0.68, 1.32)   88--104    104--113   0.92 (0.61, 1.39)
  ≥ 95th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    24--29                19--21                       1.44 (0.78, 2.68)   23--28     16--18     1.47 (0.70, 3.08)
  Abbreviations: CCA, complete case analysis; CI, confidence interval; MI, multiple imputation; OR, odds ratio; PAH, polycyclic aromatic hydrocarbon. ^*a*^Adjusted for 5-year age group, educational level, annual household income, race, religion, parity, age at first birth, body mass index (kg/m^2^), duration of HRT use, duration of oral contraceptive use, lifetime average alcohol intake, lifetime average physical activity, and duration of breastfeeding. ^*b*^Combined over 30 imputations. Sample size varies across imputed data sets.                                                                                                

The traffic B\[*a*\]P-breast cancer association was positive among women with low fruit/vegetable intake ([Table 3](#t3){ref-type="table"}), but not among women with high fruit/vegetable intake. For example, among women with low fruit/vegetable intake, we observed elevated ORs for the top 5% of 1995 exposures for this traffic PAH proxy compared with levels below the median (OR = 1.46; 95% CI: 0.89, 2.40, *p* for trend = 0.04). Among women with high fruit/vegetable intake, the corresponding OR was 0.92 (95% CI: 0.53, 1.60, *p*-interaction = 0.01). For 1960--1990 exposure, ORs for the top ≥ 75th percentile of exposure relative to exposures below the median were 1.43 (95% CI: 0.94, 2.16) among those with low fruit/vegetable intake and 0.71 (95% CI: 0.43, 1.15) among those with high fruit/vegetable intake.

###### 

Associations between traffic benzo\[a\]pyrene exposure and breast cancer incidence within strata of fruit/vegetable intake and menopausal status, Long Island Breast Cancer Study Project, 1996--1997.

  Traffic PAH exposure classification                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Cases (*n*)     Controls (*n*)   Age-adjusted OR (95% CI)   Cases (*n*)   Controls (*n*)   Age-adjusted OR (95% CI)   *p* for interaction^*a*^
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------- ---------------- -------------------------- ------------- ---------------- -------------------------- --------------------------
  Fruit/vegetable intake^*b*,*c*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Low             High                                                                                                  
  1995 (CAA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       0.01
  \< 50th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         404             431              1.00 (referent)            228           215              1.00 (referent)            
  50th to \< 75th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 193             188              1.10 (0.86, 1.41)          98            159              0.58 (0.43, 0.80)          
  75th to \< 95th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 156             132              1.24 (0.94, 1.62)          99            120              0.78 (0.56, 1.08)          
  ≥ 95th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          42              30               1.46 (0.89, 2.40)          28            29               0.92 (0.53, 1.60)          
  *p* for trend                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               0.04                                                      0.14                       
  1960--1990 (≤ 20% MI)^*d*,*e*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   0.04
  \< 50th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         169--182        174--200         1.00 (referent)            89--105       100--113         1.00 (referent)            
  50th to \< 75th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 79--92          73--84           1.19 (0.80, 1.77)          35--45        59--70           0.67 (0.39, 1.13)          
  ≥ 75th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          79--89          56--64           1.43 (0.94, 2.16)          42--49        66--72           0.71 (0.43, 1.15)          
  *p* for trend                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               0.09                                                      0.12                       
  Menopausal status^*f*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Premenopausal   Postmenopausal                                                                                        
  1995 (CCA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       0.02
  \< 50th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         190             229              1.00 (referent)            439           397              1.00 (referent)            
  50th to \< 75th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 101             122              0.95 (0.68, 1.32)          193           222              0.79 (0.62, 1.00)          
  75th to \< 95th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 91              67               1.64 (1.13, 2.38)          166           186              0.80 (0.62, 1.02)          
  ≥ 95th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          16              16               1.20 (0.58, 2.47)          51            43               1.06 (0.69, 1.63)          
  *p* for trend                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               0.04                                                      0.21                       
  1960--1990 (≤ 20% MI)^*d*,*e*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   0.50
  \< 50th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         49--66          56--73           1.00 (referent)            209--228      210--240         1.00 (referent)            
  50th to \< 75th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 23--29          29--38           0.84 (0.42, 1.66)          95--108       101--114         1.00 (0.70, 1.42)          
  ≥ 75th percentile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          23--29          19--26           1.31 (0.63, 2.71)          97--109       109--115         0.91 (0.64, 1.29)          
  *p* for trend                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               0.60                                                      0.60                       
  Abbreviations: CCA, complete case analysis; CI, confidence interval; MI, multiple imputation; OR, odds ratio. ^***a***^*p*-Values for interaction were derived using likelihood ratio tests. ^***b***^ ≥ 35 versus 0--34 servings/week (Gaudet et al. 2004). ^***c***^*n* = 26 case participants and *n*= 30 control participants from the 1995 CCA were missing information for fruit/vegetable intake. ^***d***^*n* = 27 case participants and *n*= 52 control participants from the 1995 CCA were missing information for menopausal status. ^***e***^Combined over 30 imputations. Sample size varies across imputed data sets. ^***f***^The upper quantiles were combined to avoid cell sizes of \< 10. The overall OR for the association between traffic exposure (≥ 75th vs. \< 50th percentile) and breast cancer is 1.02 (95% CI: 0.75, 1.39).                                                                                                                         

We observed some weak evidence that traffic B\[*a*\]P exposure and breast cancer incidence may be more strongly related among premenopausal women ([Table 3](#t3){ref-type="table"}). For example, the OR for the association between breast cancer and 1995 traffic B\[*a*\]P exposure (≥ 95th percentile vs. below the median) was 1.20 (95% CI: 0.58, 2.47) among premenopausal women, and 1.06 (95% CI: 0.69, 1.63) among postmenopausal women (*p*-interaction = 0.02). For 1960--1990 exposure, the ORs (≥ 75th percentile vs. below the median) were 1.31 (95% CI: 0.63, 2.71) among premenopausal women and 0.91 (95% CI: 0.64, 1.29) among postmenopausal women (*p*-interaction = 0.50).

Traffic B\[*a*\]P exposure in 1995 (top 5% vs. below the median) was more strongly associated with ER--/PR-- breast tumors (OR = 1.67; 95% CI: 0.91, 3.05), rather than ER+/PR+, ER+/PR--, or ER--/PR+ tumors (OR = 0.80; 95% CI: 0.50, 1.27; ratio of the ORs = 2.09; 95% CI: 1.08, 4.06) ([Table 4](#t4){ref-type="table"}). ORs for women with exposures in the 50th to \< 75th and 75th to \< 95th percentile ranges were below the null value. The OR for traffic B\[*a*\]P in 1995 (top 5% vs. below the median) and ER+/PR+ breast tumors was 0.86 (95% CI: 0.52, 1.41), versus 1.15 (95% CI: 0.68, 1.94) for ER+/PR--, ER--/PR+, or ER--/PR-- tumors ([Table 4](#t4){ref-type="table"}). Among case women with available traffic PAH exposure estimates, 847 out of 1,274 had information regarding their tumor hormone receptor status.

###### 

Odds ratios and 95% confidence intervals for the association between traffic benzo\[a\]pyrene exposure (1995) and tumor hormone receptor status subtypes (n = 847 case participants), Long Island Breast Cancer Study Project, 1996--1997.

  Tumor category/percentile of exposure                                                                                                                                                 Cases   Controls   Age-adjusted \[OR (95% CI)\]   Ratio of the ORs \[OR (95% CI)\]
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- ---------- ------------------------------ ----------------------------------
  ER+ and PR+ breast cancer                                                                                                                                                                                                               
  \< 50th                                                                                                                                                                               281     659        1                              
  50th to \< 75th                                                                                                                                                                       105     353        0.69 (0.53, 0.90)              1.02 (0.72, 1.46)
  75th to \< 95th                                                                                                                                                                       94      261        0.82 (0.62, 1.08)              1.05 (0.72, 1.52)
  ≥ 95th                                                                                                                                                                                23      61         0.86 (0.52, 1.41)              0.74 (0.40, 1.38)
  ER--/PR+, ER+/PR--, or ER--/PR-- breast cancer                                                                                                                                                                                          
  \< 50th                                                                                                                                                                               192     659        1                              
  50th to \< 75th                                                                                                                                                                       70      353        0.68 (0.50, 0.91)              
  75th to \< 95th                                                                                                                                                                       61      261        0.78 (0.57, 1.08)              
  ≥ 95th                                                                                                                                                                                21      61         1.15 (0.68, 1.94)              
  ER-- and PR-- breast cancer                                                                                                                                                                                                             
  \< 50th                                                                                                                                                                               97      659        1                              
  50th to \< 75th                                                                                                                                                                       41      353        0.79 (0.54, 1.16)              1.20 (0.79, 1.82)
  75th to \< 95th                                                                                                                                                                       31      261        0.81 (0.52, 1.24)              1.00 (0.64, 1.58)
  ≥ 95th                                                                                                                                                                                15      61         1.67 (0.91, 3.05)              2.09 (1.08, 4.06)
  ER+/PR--, ER--/PR+, or ER+/PR+ breast cancer                                                                                                                                                                                            
  \< 50th                                                                                                                                                                               376     659        1                              
  50th to \< 75th                                                                                                                                                                       134     353        0.66 (0.52, 0.83)              
  75th to \< 95th                                                                                                                                                                       124     261        0.81 (0.63, 1.03)              
  ≥ 95th                                                                                                                                                                                29      61         0.80 (0.50, 1.27)              
  Abbreviations: CI, confidence interval; ER, estrogen receptor; OR, odds ratio from polytomous logistic regression; PAH, polycyclic aromatic hydrocarbon; PR, progesterone receptor.                                                     

This traffic PAH proxy was also more strongly related to *in situ* rather than invasive breast cancers when evaluating women within the top quantile of exposure compared with exposures below the median ([Table 5](#t5){ref-type="table"}). The ratios of the ORs were elevated (1.5 and higher) for both 1995 and 1960--1990 exposures. For example, for 1995 exposure, the ORs for the top quantile of exposure (vs. below the median) were 1.42 (95% CI: 0.99, 2.02) for *in situ* tumors, and 0.97 (95% CI: 0.80, 1.18) for invasive tumors (ratio of the ORs = 1.46, 95% CI: 1.02, 2.09).

###### 

Associations between exposure to traffic-related polycyclic aromatic hydrocarbons (PAHs) and invasive and *in situ*breast cancer incidence,*^a^* Long Island Breast Cancer Study Project, 1996--1997.

  Traffic exposure years/percentile of exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Cases      Controls   Age-adjusted \[OR (95% CI)\]   Ratio of the ORs^*b*^\[OR (95% CI)\]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------- ---------- ------------------------------ --------------------------------------
  1995 (CCA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  *In situ*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  \< 50th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            87         659        1.0                            
  50th to \< 75th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    56         353        1.20 (0.84, 1.73)              1.48 (1.03, 2.14)
  ≥ 75th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             60         322        1.42 (0.99, 2.02)              1.46 (1.02, 2.09)
  Invasive                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  \< 50th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            558        659        1.0                            
  50th to \< 75th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    243        353        0.81 (0.66, 0.99)              
  ≥ 75th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             270        322        0.97 (0.80, 1.18)              
  75th to \< 95th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    209        261        0.93 (0.75, 1.15)              
  ≥ 95th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             61         61         1.14 (0.79, 1.66)              
  1960--1990 (≤ 20% MI)^*c*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  *In situ*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  \< 50th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            25--35     289--320   1.0                            
  50th to \< 75th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    23--27     136--155   1.71 (0.92, 3.19)              1.93 (1.03, 3.60)
  ≥ 75th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             19--23     132--140   1.63 (0.87, 3.03)              1.64 (0.87, 3.09)
  Invasive                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  \< 50th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            235--256   289--320   1.0                            
  50th to \< 75th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    98--114    136--155   0.90 (0.65, 1.25)              
  ≥ 75th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             103--115   132--140   0.95 (0.69, 1.31)              
  75th to \< 95th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    80--92     111--121   0.95 (0.68, 1.32)              
  ≥ 95th                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             21--25     19--21     1.35 (0.71, 2.56)              
  Abbreviations: CCA, complete case analysis; CI, confidence interval; MI, multiple imputation; OR, odds ratio. ^***a***^Number of women with *in situ* cancer: 1995, *n*= 203; 1960--1990, *n*= 67--85. Number of women with invasive cancer: 1995, *n*= 1,071; 1960--1990, *n*= 436--485. ^***b***^The ratio of the ORs compares quantile-specific effect estimates for *in situ* and invasive breast cancer (with invasive breast cancer treated as the referent group for the comparison). ^***c***^Combined over 30 imputations. Sample size varies across imputed data sets.                                                        

We observed no heterogeneity of the effect estimates for tumor *TP53*-mutation status subtypes. Specifically, when compared with traffic PAH exposures below the median, effect estimates for exposures in the 50th to \< 75th percentile and ≥ 75th percentile vacillated around the null value for both 1995 and 1960--1990 exposures, and the ratios of the ORs did not indicate tumor heterogeneity. For example, for 1960--1990 exposure (≥ 75th percentile vs. \< 50th percentile), the observed ORs were 1.14 (95% CI: 0.52, 2.49) for tumor *TP53*-mutation positive cancer, and 1.00 (95% CI: 0.69, 1.44) for tumor *TP53*-mutation negative cancer.

Discussion
==========

We observed a modest positive association between high-level residential exposure to vehicular traffic B\[*a*\]P, as a proxy for traffic PAHs, and breast cancer incidence in this population-based study, although estimates were imprecise and varied by the exposure duration examined. The age-adjusted odds ratios for the association were 1.14 (95% CI: 0.80, 16.4) for recent 1995 traffic B\[*a*\]P exposure and 1.44 (95% CI: 0.78, 2.68) for long-term (1960--1990) exposure when comparing participants with exposure levels at or above the 95th percentile with participants with exposures under the median. The corresponding odds ratios for the association between recent exposure to this traffic PAH proxy and breast cancer were 1.46 (95% CI: 0.89, 2.40) among women with low fruit/vegetable intake, and 1.67 (95% CI: 0.91, 3.05) among those with hormone receptor--negative breast tumors. U.S. traffic PAH emissions are greatly reduced from the high levels of the 1960s and 1970s, but annual traffic kilometers driven is increasing ([@r4]). Our results may have increased public health significance outside the United States, given widespread exposure to traffic pollution throughout the world and delayed introduction of vehicle pollution controls. For instance, tailpipe PAH reductions comparable to those in the United States did not occur in Europe until the late 1990s ([@r4]).

Traffic pollution is a major ambient source of indoor and outdoor ambient PAHs ([@r17]; [@r40]), especially near cities ([@r10]). Source apportionment studies conducted in urban areas have reported that approximately 40--90% of ambient PAH levels are explained by vehicular traffic emissions, depending on various factors such as degree of urbanization or day of the week ([@r23]; [@r40]).

Previous studies have consistently reported elevated associations between residential air pollution exposure and breast cancer risk ([@r8]; [@r14]; [@r33]; [@r39]; [@r42]). For example, a breast cancer study conducted in Buffalo, New York, reported elevated odds ratios when comparing the highest and lowest quartiles of overall and traffic-related particulate pollution exposure in an area with high industrial emissions \[OR = 2.42; 95% CI: 0.97, 6.09 for exposure at birth, or OR = 2.57; 95% CI: 1.16, 5.69 for exposure at the time of a woman's first birth ([@r8]; [@r39])\]. The latter study, by [@r39], used an adapted version of the model developed for the LIBCSP. Other investigators examined continuous traffic-related nitrogen oxide levels, reporting, for example, an elevated OR of 1.31 (95% CI: 1.00, 1.71) for each 5-ppb increase in nitrogen dioxide ([@r14]), or an OR of 1.16 (95% CI: 0.89, 1.51) for each 100-μg/m^3^ increase in nitrogen oxides ([@r42]). Finally, a study reported an elevated association between high residential traffic density in Nassau County but not Suffolk County in Long Island, NY \[pollution levels are higher in Nassau County ([@r33])\]. The study by [@r33] was conducted in the same two counties as our investigation.

Some previous studies estimated exposure to air pollution, a complex mixture, using relatively sparse monitors ([@r8]), simple traffic density data ([@r33]), or reconstructed exposure to nitrogen oxides rather than carcinogenic particulate pollution ([@r14]; [@r42]). Two studies compared their exposure estimates against measured, related proxies ([@r39]; [@r42]). Most studies evaluated relatively brief periods of exposure. Overall, based on an informal qualitative assessment, positive results were reported across studies despite differences in exposure assessment, exposure levels and timing, study design, and participant characteristics between study populations. When stratifying analyses by menopausal status, study results were inconsistent across investigations, suggesting that timing, magnitude of exposure, and/or pollutant mix may play important roles, although such differences could also be explained by random chance.

Strengths of our study include long-term, individualized traffic B\[*a*\]P exposure estimates generated from an exposure model that incorporated information regarding historical tailpipe emissions, local traffic patterns, meteorological conditions, pollutant dispersion, deposition and decay data, proximity to intersections, and background PAHs ([@r2]). Participants also had a wide range of estimated exposures due to the gradient of urbanization across the study area ([@r2]). In addition, the LIBCSP is a large, population-based study with detailed information regarding many covariates, which facilitates controlling for confounders, assessing effect modification, and evaluating heterogeneity within breast cancer subtypes ([@r19]).

We estimated stronger associations between traffic B\[*a*\]P exposure and breast cancer incidence among women with low fruit/vegetable intake, consistent with a previous LIBCSP report that found that associations with grilled/smoked meat intake---another PAH source---were more pronounced among participants who consumed low levels of fruits/vegetables ([@r51]). Similarly, fruit/vegetable intake was negatively associated with PAH--DNA adduct levels measured in peripheral leukocytes, both in the LIBCSP ([@r48]) and in an epidemiologic study conducted in Europe ([@r41]). Components of fruits and vegetables have antioxidant and other chemopreventive properties and decrease carcinogenic effects of PAHs in animals ([@r25]; [@r29]). To our knowledge, ours is the first population-based breast cancer study to evaluate interactions between air pollution and fruit and vegetable intake; thus, our results require confirmation. We also observed inverse associations between traffic and breast cancer in the high fruit/vegetable intake group, which is consistent with previous research showing that PAH-related tumor induction is reduced by high antioxidant intake ([@r26]), but may also be due to chance.

Traffic B\[*a*\]P--breast cancer associations appeared to be stronger among premenopausal women in our study, although the greatest difference was noted within the 75th to 95th percentile traffic exposure subgroup, rather than within the top 5%, and we also saw some unexpected negative associations between traffic exposure and breast cancer among postmenopausal women. Stronger associations with premenopausal rather than postmenopausal breast cancer were observed in previous LIBCSP reports regarding combined active/passive smoking exposure ([@r18]) and PAH--DNA adducts ([@r21]). Similarly, a recent systematic review concluded that associations between environmental tobacco smoke and premenopausal, but not postmenopausal, breast cancer were "consistent with causality" ([@r30]). We also found stronger associations with traffic B\[*a*\]P among women with ER--/PR-- breast tumors, which are overrepresented among premenopausal women ([@r11]), although this finding was based on a small number of cases. Previous studies conducted in an area with high industrial emissions reported positive associations between air pollution and both premenopausal and postmenopausal breast cancer that varied according to the exposure definition used; the associations in these studies did not vary by tumor hormone-receptor subtype ([@r8]; [@r39]).

Associations between traffic B\[*a*\]P and breast cancer were stronger among women with *in situ* rather than invasive breast tumors when evaluating women within the top quantile of exposure (vs. below the median). A possible explanation for these findings is that PAHs may act earlier in the carcinogenic process ([@r35]), similar to the way in which smoking may sometimes be more strongly related to colorectal adenomas, rather than to invasive colorectal cancer ([@r52]). Other possible explanations are the influence of potential diagnostic bias in identifying *in situ* breast tumors, or random chance. The sample size was much smaller in the subgroup of participants with *in situ* breast cancer than in the subgroup of participants with invasive breast cancer; thus, the results among the *in situ* group are more unstable. In addition, we were unable to evaluate regressions for participants with the top 5% of exposures when evaluating *in situ* breast cancer owing to sample size constraints. Instead, we evaluated broader quantiles of exposure (\< 50th, 50th to \< 75th, ≥ 75th percentiles), which may have obscured some patterns of association. Associations between traffic B\[*a*\]P and invasive breast cancer were positive, though imprecise, among those with the top 5% of exposure levels, compared with below the median (1995: OR = 1.14, 95% CI: 0.79, 1.66; 1960--1990: OR = 1.35, 95% CI: 0.71, 2.56).

Traffic B\[*a*\]P was not related to tumor *TP53*-mutation status in our study, although the number of case women with *TP53*-mutation--positive tumor tissue and high traffic exposure estimates was low. This null result was consistent with an LIBCSP report evaluating active and passive smoking, grilled/smoked meat intake, and PAH--DNA adducts ([@r36]). Active, but not passive, smoking was associated with *TP53*-mutation positive breast cancer in a smaller population study ([@r13]).

Several mechanisms potentially underlie the observed association between traffic-related B\[*a*\]P, as a proxy for overall particulate vehicular traffic PAH exposure, and breast cancer incidence. PAHs are genotoxic, damaging DNA primarily through the formation of PAH--DNA adducts; they may also induce inflammation and oxidative stress, resulting in oxidative DNA lesions ([@r28]). Uncorrected DNA damage can cause somatic mutations in tumor suppressor genes or proto-oncogenes, which could in turn contribute to carcinogenesis ([@r20]; [@r28]).

Limitations of our study include some missing address information, which was corrected in part through multiple imputation. Our results were robust to varying the percentage of imputation allowed, increasing confidence that our imputation method does not introduce artificial results ([@r5]). Similarly, although analyses for exposure in 1960--1990 included roughly half of the study participants and may not be representative of the full study population ([@r19]), only evaluating 1 recent year of exposure also carries implicit assumptions and associated biases related to missing exposures.

An additional limitation of our study is that the exposure model did not generate non-residential traffic PAH exposure estimates. A nationwide study reported that, on average, American men and women spend almost 70% of their day inside (64.97%) or just outside (2.50%) of their residences, both throughout the United States and in one large city (Chicago, IL) ([@r32]). A Canadian study found similar results among women only ([@r37]). Our results were not adjusted for multiple comparisons, although we used a targeted approach and carefully selected factors that were likely to interact with traffic PAHs. Our results may also be influenced by potential selection bias, given that our response rates among the control participants were lower than anticipated ([@r19]). The hormone receptor subtype results may be subject to selection bias as well, given that only a subset of case participants (847 out of 1,274) were available for these analyses. However, responses among the control participants are comparable to those among other large population-based case--control studies conducted in the 1990s ([@r38]).

The purpose of our exposure model was to estimate vehicular traffic PAH exposures; thus, by design, we did not incorporate information on non-traffic sources of ambient PAHs, such as environmental tobacco smoke, cooking, or heating ([@r5]). Traffic is often the largest source of ambient PAHs near urban areas ([@r17]; [@r40]) and generates smaller, more inflammatory particles than some other ambient sources ([@r31]).

B\[*a*\]P was modeled as a surrogate for all traffic PAHs. Traffic pollution contains many chemicals, including many PAHs and other confirmed carcinogens ([@r10]). It is impossible to ascribe health effects to a single traffic pollutant based on an observational study. However, B\[*a*\]P is one of the most carcinogenic PAHs and is representative of overall PAH exposure from vehicle exhaust ([@r10]), and particulate PAHs are among the most carcinogenic components of traffic exhaust ([@r9]). Studies conducted throughout the United States indicate that historical traffic-related B\[*a*\]P emissions closely track emissions for all other measured traffic-related PAHs ([@r4]). Furthermore, many types of traffic pollutants have differing distributions ([@r2]). In our study, exposures were modeled using PAH-specific emissions data and dispersion parameters and were validated and calibrated against soil PAH levels ([@r2]). Although studies of air pollution exposure and traffic pollution have been conducted in the United States, Canada, and Europe, where traffic emission levels are currently fairly low, future studies should examine associations between traffic exposure and breast cancer within more highly exposed populations.

Conclusions
===========

We observed modest positive associations between breast cancer incidence and comparatively high levels of residential traffic B\[*a*\]P, particularly among women with low fruit and vegetable intake and hormone receptor--negative tumors, although the effect estimates were imprecise and several exposure durations and participant subgroups were evaluated. Future studies should examine associations between breast cancer and traffic PAH exposure at different points across the life-course and in combination with other PAH sources, and should evaluate interactions between traffic PAHs and genetic variants in relevant pathways. Our results strengthen the plausibility of a relationship between vehicular traffic PAHs and breast cancer incidence and provide new data on potentially susceptible subgroups of women.
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